陳 雅萍

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma 60%
3. Neoplasms 58%
4. Drug Therapy 56%
5. Lymphoma 54%
6. Follicular Lymphoma 52%
7. T-Cell Lymphoma 47%
8. Epstein-Barr virus EBV-associated membrane antigen 46%
9. Dengue Virus 40%
10. Bone Marrow 37%
11. RV 538 35%
12. Typhlitis 35%
13. T-Lymphocytes 34%
14. interleukin 20 33%
15. ceramide glucosyltransferase 33%
16. arginine deiminase 32%
17. Mycobacterium kansasii 32%
18. B-Lymphocytes 32%
19. Lymphocytes 32%
20. Hemophagocytic Lymphohistiocytosis 31%
21. Peripheral T-Cell Lymphoma 30%
22. Klebsiella oxytoca 30%
23. Aurora Kinase A 30%
24. Membrane Proteins 30%
25. Platelet-Derived Growth Factor alpha Receptor 28%
26. Chelation Therapy 28%
27. Glucosephosphate Dehydrogenase Deficiency 28%
28. Glycogen Synthase Kinase 3 27%
29. Mycobacterium Infections 27%
30. Thrombotic Thrombocytopenic Purpura 27%
31. Therapeutics 25%
32. Hemangiosarcoma 25%
33. Thalidomide 25%
34. Intussusception 25%
35. Cytogenetics 25%
36. Histiocytes 24%
37. Thymoma 24%
38. Lymphadenopathy 24%
39. Antiemetics 24%
40. Langerhans Cells 24%
41. Natural Killer T-Cells 24%